CER comparative effectiveness research

CHOP cyclophosphamide, doxorubicin, vincristine, and prednisone

CIRB central institutional review board

CLL chronic lymphocytic leukemia

CMS Centers for Medicare & Medicaid Services

COG Children’s Oncology Group

CRADA Cooperative Research and Development Agreement

CRI Clinical Research Initiative (Association of American Cancer Institutes)

CSDD Center for the Study of Drug Development

CT computed tomography

CTAC Clinical Trials Advisory Committee

CTEP Cancer Therapy Evaluation Program

CTMB Clinical Trials Monitoring Branch

CTROC Clinical Trials and Translational Research Operations Committee

CTSA Clinical and Translational Science Awards

CTSU Cancer Trials Support Unit

CTTI Clinical Trials Transformation Initiative

CTU Clinical Trials Unit

CTWG Clinical Trials Working Group

CYP2D6 cytochrome P-450 2D6

DCE-MRI dynamic contrast-enhanced magnetic resonance imaging

DCPC Division of Cancer Prevention and Control

DCTD Division of Cancer Treatment and Diagnosis

DCTDC Division of Cancer Treatment, Diagnosis, and Centers

ECOG Eastern Cooperative Oncology Group

EGFR epidermal growth factor receptor

EMR electronic medical record

EORTC European Organisation for Research and Treatment of Cancer

ER estrogen receptor

ERISA Employee Retirement Income Security Act of 1974

5-FU fluorouracil

18F-FDG fluorine-18 fluorodeoxyglucose

FDA Food and Drug Administration

FDAAA Food and Drug Administration Amendments Act of 2007

FNIH Foundation for the National Institutes of Health

FOLFOX4 oxaliplatin, 5-fluorouracil, and leucovorin

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement